DistantNews
Support us
🇹🇼 Taiwan /Health & Science

Netherlands sees Trump-shaped ecstasy pills, agency warns of fatal risks

From Liberty Times · () Chinese

Translated from Chinese and summarized by DistantNews. Read the original for the full story.

At a glance

News Sources not specified Context piece
  • The Trimbos Institute in the Netherlands has warned of fatal risks associated with ecstasy pills shaped like former U.S. President Donald Trump.
  • These pills have tested positive for para-methoxymethamphetamine (PMMA), a substance known as "super ecstasy" or "death."
  • PMMA's delayed effects compared to MDMA can lead users to take more, increasing the risk of overdose and death.

Health authorities in the Netherlands are issuing a stark warning about a new and potentially lethal form of ecstasy circulating on the market: pills shaped like former U.S. President Donald Trump.

The Trimbos Institute, a national center for addiction and mental health research, confirmed on August 28 that these distinctive pills contain para-methoxymethamphetamine, commonly known as PMMA. This substance is significantly more dangerous than MDMA, the typical active ingredient in ecstasy, and is sometimes referred to as "super ecstasy" or "death."

According to reports, PMMA's effects manifest more slowly than MDMA. This delay can trick users into believing the drug is not potent, leading them to consume additional pills. This pattern of use dramatically increases the risk of a dangerous overdose, which can be fatal.

The institute urges the public to be aware of the extreme dangers posed by these pills. The warning highlights the unpredictable nature of illicit drug markets and the potentially deadly consequences of consuming substances with unknown or altered chemical compositions.

commonly known as 'super ecstasy' or 'death.'

— Trimbos InstituutDescribing the dangerous nature of PMMA.
About this summary

Originally published by Liberty Times in Chinese. Translated, summarized, and contextualized automatically by DistantNews, with a note on how the source frames the story. Not individually reviewed before publishing. How this works.

More Stories

From Our Blog